论文部分内容阅读
目的探究采用雷公藤多苷联合他巴唑与强的松在甲状腺功能亢进患者突眼治疗中的临床疗效。方法 122例患者接受雷公藤多苷联合他巴唑与强的松的治疗方法,通过翻阅记录资料,在数据处理分析的基础上,通过综合判断,得出结论。结果采用雷公藤多苷联合他巴唑与强的松的疗法治愈甲状腺患者突眼的成功率达59.0%,9.8%未得到改善。结论临床上对于甲亢突眼采取雷公藤多苷联合他巴唑与强的松的疗法有显著疗效,减少了单独使用化学药物(他巴唑与强的松)带来的副作用,康复时间缩短。
Objective To investigate the clinical efficacy of tripterygium glycosides combined with methimazole and prednisone in the treatment of exophthalmos in patients with hyperthyroidism. Methods 122 patients received tripterygium glycosides combined with methimazole and prednisone treatment methods, by reading the recorded data, based on the data processing and analysis, through comprehensive judgments, draw conclusions. Results The success rate of using tripterygium glycosides combined with methimazole and prednisone to cure patients with thyroid gout was 59.0% and 9.8% did not improve. Conclusions The treatment of hyperthyroidism with tripterygium glycosides combined with methimazole and prednisone is clinically effective and reduces the side effects caused by chemotherapy alone (methimazole and prednisone) and shortens the recovery time.